SIMCERE PHARMACEUTICAL GROUP Operating Income
SIMCERE PHARMACEUTICAL GROUP reported Operating Income of CNY 39.56 million for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2013-04-26
CNY
| Period end | Operating Income (Loss) 12 month |
|---|---|
| 2012-12-31 | 39.56M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 143.55M CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 217.92M CNY 20-F · filed 2013-04-26 |
| 2009-12-31 | 102.21M CNY 20-F · filed 2012-04-25 |
USD
| Period end | Operating Income (Loss) 12 month |
|---|---|
| 2012-12-31 | $6.35M 20-F · filed 2013-04-26 |